EUVIMEDEUVIMED entdecken
Crossref

Incidence and mortality of mucous membrane pemphigoid in France

Alexis Lefebvre iD, André Gillibert iD, Emmanuelle Tancrede-Bohin, Louise Loridon, Clémence Lepelletier, Florian Lombart, Anne Pham-Ledard, Claire Abasq, Saskia Oro iD, Sophie Duvert-Lehembre, Philippe Modiano, Coralie Becquart und 18 weitere

British Journal of Dermatology · 18.08.2026 · 195 (3) · 441-450

DOI: 10.1093/bjd/ljag180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 11.05.2026. Verfasst von Alexis Lefebvre und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and INSERM U 1234, Centre de référence des maladies bulleuses auto-immunes, Normandie University, Rouen University Hospital…. Hauptthemen laut MEDLINE: Pemphigoid, Benign Mucous Membrane. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: French Society of Dermatology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on the incidence and mortality rates of mucous membrane pemphigoid (MMP) are limited and outdated.

Objectives

To estimate the incidence and standardized mortality ratios (SMR) of MMP and identify prognostic factors for mortality.

Methods

We screened patients with MMP diagnosed in 20 dermatology departments in France between 2000 and 2021, using 3 national databases. The incidence rate was calculated based on the number of inhabitants in the corresponding administrative regions and patients’ vital status was obtained from the French Institut national de la statistique et des études économiques (INSEE) death register.

Results

A total of 663 patients (376 women, 287 men) with a mean (SD) age of 70.57 (13.58) years was included. Annualized incidence rates progressively increased over the years, from 1.38 cases per million inhabitants per year in 2012 to a peak of 3.86 in 2019. The highest annualized incidence rate was observed in patients aged between 80 and 85 years [9.91 cases per million inhabitants per year; 95% confidence interval (CI) 6.43–15.28]. The 1-, 3- and 5-year SMRs were 1.00 (95% CI 0.73–1.33), 1.05 (95% CI 0.85–1.26) and 1.01 (95% CI 0.85–1.18), respectively. A higher SMR was observed in patients with ear, nose and throat (ENT) involvement (SMR 1.26, 95% CI 1.00–1.55). Predictors of mortality included age [hazard ratio (HR) 3.65 for ages 75–85 years vs. < 65 years (95% CI 1.67–7.99; P = 0.001) and 11.94 for ages > 85 years (95% CI 5.40–26.41; P < 0.001)], cancer (HR 2.66, 95% CI 1.75–4.06; P < 0.001) and diabetes (HR 1.80, 95% CI 1.17–2.77; P = 0.008). Patients with ocular-only involvement (HR 1.96, 95% CI 0.95–4.05; P = 0.07) and ENT involvement (HR 1.63, 95% CI 0.96–2.78; P = 0.07) had a trend towards a higher risk of mortality compared with oral forms of MMP.

Conclusions

The incidence rate of MMP in France has more than doubled over the last decade. Ocular-only and ENT involvement are associated with a higher risk of mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pemphigoid, Benign Mucous MembraneHumansFemaleFranceMaleIncidenceAgedAged, 80 and overMiddle AgedAge DistributionAdultPrognosisAdolescent

Autor:innen und Institutionen

  • Department of Dermatology and INSERM U 1234, Centre de référence des maladies bulleuses auto-immunes, Normandie University, Rouen University Hospital, Rouen, France.

ORCID-Profile: Alexis Lefebvre, André Gillibert, Saskia Oro, Sébastien Debarbieux, Billal Tedbirt

Förderung

  • French Society of Dermatology

Zitieren

APA

Lefebvre, A., Gillibert, A., Tancrede-Bohin, E., Loridon, L., Lepelletier, C., Lombart, F., Pham-Ledard, A., Abasq, C., Oro, S., Duvert-Lehembre, S., Modiano, P., Becquart, C., Bédane, C., Quéreux, G., Picard-Dahan, C., Dupin, N., Viguier, M., Muller, C., Jullien, D., …, & French Study Group on Autoimmune Blistering Diseases and French Network for rare skin disorders (FIMARAD) (2026). Incidence and mortality of mucous membrane pemphigoid in France. British Journal of Dermatology, 195(3), 441-450. https://doi.org/10.1093/bjd/ljag180

Vancouver

Lefebvre A, Gillibert A, Tancrede-Bohin E, Loridon L, Lepelletier C, Lombart F, et al. Incidence and mortality of mucous membrane pemphigoid in France. British Journal of Dermatology. 2026;195(3):441-450. doi:10.1093/bjd/ljag180

BibTeX
@article{Lefebvre2026,
  author = {Lefebvre, Alexis and Gillibert, André and Tancrede-Bohin, Emmanuelle and Loridon, Louise and Lepelletier, Clémence and Lombart, Florian and Pham-Ledard, Anne and Abasq, Claire and Oro, Saskia and Duvert-Lehembre, Sophie and Modiano, Philippe and Becquart, Coralie and Bédane, Christophe and Quéreux, Gaëlle and Picard-Dahan, Catherine and Dupin, Nicolas and Viguier, Manuelle and Muller, Céline and Jullien, Denis and Chastagner, Marine and Jeudy, Géraldine and Richard, Marie-Aleth and Morice, Cécile and Litrowski, Noémie and Debarbieux, Sébastien and Grosjean, Julien and Hébert, Vivien and Joly, Pascal and Tedbirt, Billal and French Study Group on Autoimmune Blistering Diseases and French Network for rare skin disorders (FIMARAD), French Study Group on Autoimmune Blistering Diseases and French Network for rare skin disorders (FIMARAD)},
  title = {Incidence and mortality of mucous membrane pemphigoid in France},
  journal = {British Journal of Dermatology},
  year = {2026},
  volume = {195},
  number = {3},
  pages = {441--450},
  doi = {10.1093/bjd/ljag180}
}
Kostenlos starten →